Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:33:44.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A temporary NIH announcement about terminology during a website transition appears above the ClinicalTrials.gov error page, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T17:13:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T18:56:45.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the usual study details and links. This indicates an access issue rather than a substantive update to the study record.
    Difference
    18%
    Check dated 2026-09-22T22:34:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, reflecting a site update. The change only affects the version tag and does not modify the trial details or how the page functions.
    Difference
    0.0%
    Check dated 2026-09-15T22:02:19.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's version. It does not indicate changes to study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-09-01T19:53:22.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.